Acasti Pharma reported $20K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Addus HomeCare USD 134.05M 6.05M Sep/2025
Amarin USD 127.31M 8.18M Sep/2025
Cassava Sciences USD 817K 18K Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Option Care Health USD 474.5M 6.75M Sep/2025
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Tilray USD 121.49M 18.12M Mar/2025